Why Varicella-Zoster Virus Vaccine Live Attenuated is in shortage
unexpected increases in demand — e.g. “Toegenomen vraag” (Belgium)
Recent shortage history
Iceland: resolved 30 Jun 2026 (began 21 Jun 2026)
Iceland: resolved 5 Dec 2025 (began 5 Dec 2025)
Canada: resolved (began 9 Aug 2024)
Frequently asked questions
Is Varicella-Zoster Virus Vaccine Live Attenuated currently in shortage?
Yes. As of the latest regulator updates, Varicella-Zoster Virus Vaccine Live Attenuated has 1 active shortage notice across 1 country (Belgium). Status is refreshed daily from official regulatory sources.
Why is Varicella-Zoster Virus Vaccine Live Attenuated in shortage?
Regulators attribute the current Varicella-Zoster Virus Vaccine Live Attenuated shortages to unexpected increases in demand. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Varicella-Zoster Virus Vaccine Live Attenuated shortage be resolved?
Regulator-estimated resolution dates currently range from 5 Oct 2026 to 5 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Varicella-Zoster Virus Vaccine Live Attenuated shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Varicella-Zoster Virus Vaccine Live Attenuated status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.